Arhalofenate acid inhibits monosodium urate crystal-induced inflammatory responses through activation of AMP-activated protein kinase (AMPK) signaling

MLA

Charles McWherter, et al. “Arhalofenate Acid Inhibits Monosodium Urate Crystal-Induced Inflammatory Responses through Activation of AMP-Activated Protein Kinase (AMPK) Signaling.” Arthritis Research & Therapy, vol. 20, no. 1, Sept. 2018, pp. 1–11. EBSCOhost, https://doi.org/10.1186/s13075-018-1699-4.

APA

Charles McWherter, Yun-Jung Choi, Ramon L. Serrano, Sushil K. Mahata, Robert Terkeltaub, & Ru Liu-Bryan. (2018). Arhalofenate acid inhibits monosodium urate crystal-induced inflammatory responses through activation of AMP-activated protein kinase (AMPK) signaling. Arthritis Research & Therapy, 20(1), 1–11. https://doi.org/10.1186/s13075-018-1699-4

Chicago

Charles McWherter, Yun-Jung Choi, Ramon L. Serrano, Sushil K. Mahata, Robert Terkeltaub, and Ru Liu-Bryan. 2018. “Arhalofenate Acid Inhibits Monosodium Urate Crystal-Induced Inflammatory Responses through Activation of AMP-Activated Protein Kinase (AMPK) Signaling.” Arthritis Research & Therapy 20 (1): 1–11. doi:10.1186/s13075-018-1699-4.